Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Organisation › Details

Sanofi (Group) [since May 2011]

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

Period Start 2011-05-06 renamed
  Predecessor Sanofi-Aventis (Group)
Product Industry pharmaceutical
Persons Person Brandicourt, Olivier (Sanofi 201508 CEO before CEO of Bayer HealthCare before Pfizer Inc)
  Person 2 Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
     
Region Region Paris
  Country France
  Street 174 avenue de France
  City 75635 Paris
  Tel +33-1-5377-4000
    Address record changed: 2012-01-11
     
Basic data Employees I: 50,001 to 100,0 (2019-02-06)
  Currency EUR
  Annual sales 34,463,000,000 (sales, net, consolidated (2018) 2018-12-31)
  Profit 4,410,000,000 (2018-12-31)
  Cash 2,633,000,000 (2018-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Sanofi (Group) [since May 2011]


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top